152 related articles for article (PubMed ID: 7511336)
1. Heterologous expression of delta F508 CFTR results in decreased sialylation of membrane glycoconjugates.
Dosanjh A; Lencer W; Brown D; Ausiello DA; Stow JL
Am J Physiol; 1994 Feb; 266(2 Pt 1):C360-6. PubMed ID: 7511336
[TBL] [Abstract][Full Text] [Related]
2. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
Denning GM; Anderson MP; Amara JF; Marshall J; Smith AE; Welsh MJ
Nature; 1992 Aug; 358(6389):761-4. PubMed ID: 1380673
[TBL] [Abstract][Full Text] [Related]
3. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.
Yang Y; Janich S; Cohn JA; Wilson JM
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9480-4. PubMed ID: 7692448
[TBL] [Abstract][Full Text] [Related]
4. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of CFTR bearing the delta F508 mutation.
Welsh MJ; Denning GM; Ostedgaard LS; Anderson MP
J Cell Sci Suppl; 1993; 17():235-9. PubMed ID: 7511616
[TBL] [Abstract][Full Text] [Related]
6. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
[TBL] [Abstract][Full Text] [Related]
7. The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells.
Lukacs GL; Chang XB; Bear C; Kartner N; Mohamed A; Riordan JR; Grinstein S
J Biol Chem; 1993 Oct; 268(29):21592-8. PubMed ID: 7691813
[TBL] [Abstract][Full Text] [Related]
8. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR.
Li C; Ramjeesingh M; Reyes E; Jensen T; Chang X; Rommens JM; Bear CE
Nat Genet; 1993 Apr; 3(4):311-6. PubMed ID: 7526932
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural localization of variant forms of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial of xenografts.
Yang Y; Engelhardt JF; Wilson JM
Am J Respir Cell Mol Biol; 1994 Jul; 11(1):7-15. PubMed ID: 7517144
[TBL] [Abstract][Full Text] [Related]
10. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
[TBL] [Abstract][Full Text] [Related]
11. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells.
Rich DP; Anderson MP; Gregory RJ; Cheng SH; Paul S; Jefferson DM; McCann JD; Klinger KW; Smith AE; Welsh MJ
Nature; 1990 Sep; 347(6291):358-63. PubMed ID: 1699126
[TBL] [Abstract][Full Text] [Related]
12. Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression.
Cheng SH; Fang SL; Zabner J; Marshall J; Piraino S; Schiavi SC; Jefferson DM; Welsh MJ; Smith AE
Am J Physiol; 1995 Apr; 268(4 Pt 1):L615-24. PubMed ID: 7733303
[TBL] [Abstract][Full Text] [Related]
13. Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.
Teem JL; Berger HA; Ostedgaard LS; Rich DP; Tsui LC; Welsh MJ
Cell; 1993 Apr; 73(2):335-46. PubMed ID: 7682896
[TBL] [Abstract][Full Text] [Related]
14. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
Brown CR; Hong-Brown LQ; Biwersi J; Verkman AS; Welch WJ
Cell Stress Chaperones; 1996 Jun; 1(2):117-25. PubMed ID: 9222597
[TBL] [Abstract][Full Text] [Related]
15. A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation.
Guay-Broder C; Jacobson KA; Barnoy S; Cabantchik ZI; Guggino WB; Zeitlin PL; Turner RJ; Vergara L; Eidelman O; Pollard HB
Biochemistry; 1995 Jul; 34(28):9079-87. PubMed ID: 7542476
[TBL] [Abstract][Full Text] [Related]
16. Mutant (delta F508) cystic fibrosis transmembrane conductance regulator Cl- channel is functional when retained in endoplasmic reticulum of mammalian cells.
Pasyk EA; Foskett JK
J Biol Chem; 1995 May; 270(21):12347-50. PubMed ID: 7539001
[TBL] [Abstract][Full Text] [Related]
17. Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium.
Sheppard DN; Carson MR; Ostedgaard LS; Denning GM; Welsh MJ
Am J Physiol; 1994 Apr; 266(4 Pt 1):L405-13. PubMed ID: 7513963
[TBL] [Abstract][Full Text] [Related]
18. Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator.
Zhang XM; Wang XT; Yue H; Leung SW; Thibodeau PH; Thomas PJ; Guggino SE
J Biol Chem; 2003 Dec; 278(51):51232-42. PubMed ID: 14532265
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of a delta F508 cystic fibrosis mouse model.
Colledge WH; Abella BS; Southern KW; Ratcliff R; Jiang C; Cheng SH; MacVinish LJ; Anderson JR; Cuthbert AW; Evans MJ
Nat Genet; 1995 Aug; 10(4):445-52. PubMed ID: 7545494
[TBL] [Abstract][Full Text] [Related]
20. Genistein potentiates wild-type and delta F508-CFTR channel activity.
Hwang TC; Wang F; Yang IC; Reenstra WW
Am J Physiol; 1997 Sep; 273(3 Pt 1):C988-98. PubMed ID: 9316420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
